Loading…
Continue Reading
Related articles from the knowledge base
THE SCIENCE
Most of what's written about tDCS falls into two camps: dramatic before-and-afters, or dismissive write-offs. Neither is accurate. Here's what the research actually shows.
Loading…
Continue Reading
Related articles from the knowledge base
FREQUENTLY ASKED
Yes, at standard parameters of 1–2 mA. A 2016 safety review of 33,200+ sessions across 1,000+ subjects reported no serious adverse events within the ≤4 mA, ≤40-minute envelope. Sychedelic operates at 2 mA for 20 minutes with hardware-enforced limits, in-app contraindication screening, CDSCO approval, and ISO 60601-1-2 certification.
The neurophysiological effects are well-documented across decades of research. Behavioral effects depend on protocol. Single-session tDCS in rested healthy adults often shows no measurable benefit. Multi-session, task-paired, well-targeted protocols show small but statistically real effects (d ≈ 0.3–0.5) across multiple meta-analyses.
A 20-minute tDCS session at 2 mA produces a post-stimulation excitability window of approximately 20 to 90 minutes. During this window, cortical excitability remains elevated, making the brain more responsive to active cognitive work. Durable changes require repeated sessions across weeks, not single applications.
Sychedelic targets the dorsolateral prefrontal cortex (DLPFC) at the F3 and F4 positions of the international 10-20 EEG system. The DLPFC is the most studied stimulation site for working memory, executive function, and stress-related cognitive degradation, supported by 67+ peer-reviewed studies.
Each addresses a different limitation. PPG biosensing reads heart-rate variability at 100 Hz to confirm a regulated nervous system state. Alpha binaural beats reset frontal arousal first. tDCS then modulates DLPFC excitability when the system confirms readiness. Together, they form a closed loop. Individually, each has documented limitations.
The PPG sensor uses light to detect blood-volume changes near the superficial temporal artery, sampling at 100 Hz. From this signal, Sychedelic derives heart-rate variability metrics RMSSD and LF/HF ratio, which reflect autonomic nervous system balance and tell the device whether you are in a suitable state for stimulation.
Absolute contraindications include active epilepsy or seizure disorder, implanted cardiac devices (pacemakers, ICDs), and medications that significantly lower the seizure threshold. Additional precautions apply for pregnancy, active scalp conditions at electrode sites, and metal implants near the head. Sychedelic enforces all contraindications via in-app screening before every session.
THE INSTRUMENT
Sychedelic combines everything described in this article into one 20-minute protocol.